• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Co-Founder, CEO Radke Jeffrey L

    7/25/25 8:35:43 PM ET
    $ARX
    Specialty Insurers
    Finance
    Get the next $ARX alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    RADKE JEFFREY L

    (Last) (First) (Middle)
    UNIT 106, WINDWARD 3
    REGATTA OFFICE PARK, WEST BAY ROAD

    (Street)
    GRAND CAYMAN E9 KY1-1108

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Accelerant Holdings [ ARX ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Co-Founder, CEO
    3. Date of Earliest Transaction (Month/Day/Year)
    07/23/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Stock Option (Right to Buy) $21 07/23/2025 A 8,279,552 (1) 07/23/2035 Class A Common Shares 8,279,552 $0 8,279,552 D
    Explanation of Responses:
    1. Twenty-five percent (25%) of the Class A Common Shares subject to the option vest on July 23, 2026 (the one-year anniversary of the grant date), and the remaining Class A Common Shares subject to the option vest in 6.25% quarterly installments through July 23, 2029 (the four-year anniversary of the grant date), in each case subject to the Reporting Person's continuous service.
    /s/ Robert Hardy, Attorney-in-Fact 07/25/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ARX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARX

    DatePrice TargetRatingAnalyst
    12/4/2025$20.00Mkt Perform → Mkt Outperform
    Citizens JMP
    10/6/2025$19.50Neutral → Buy
    Goldman
    8/18/2025$35.00Overweight
    Piper Sandler
    8/18/2025Outperform
    William Blair
    8/18/2025$33.00Outperform
    Raymond James
    8/18/2025$34.00Outperform
    BMO Capital Markets
    8/18/2025$30.00Neutral
    Goldman
    8/18/2025Mkt Perform
    Citizens JMP
    More analyst ratings

    $ARX
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Accelerant Holdings

    SCHEDULE 13G - Accelerant Holdings (0001997350) (Subject)

    11/14/25 4:56:35 PM ET
    $ARX
    Specialty Insurers
    Finance

    SEC Form SCHEDULE 13G filed by Accelerant Holdings

    SCHEDULE 13G - Accelerant Holdings (0001997350) (Subject)

    11/13/25 7:06:13 PM ET
    $ARX
    Specialty Insurers
    Finance

    SEC Form 10-Q filed by Accelerant Holdings

    10-Q - Accelerant Holdings (0001997350) (Filer)

    11/12/25 4:31:30 PM ET
    $ARX
    Specialty Insurers
    Finance

    $ARX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Accelerant Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call

    Accelerant Holdings (NYSE:ARX), a leading technology company operating a data-driven risk exchange platform for the specialty insurance market, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the market opens on Thursday, March 19, 2026. Accelerant will host a webcast and conference call to discuss fourth quarter and full year financial results at 8:00 A.M. Eastern Time. Webcast and Conference Call Details When: March 19, 2026 at 8:00 A.M. Eastern Time. Webcast: A live webcast of the call can be accessed from the Investor Relations section of Accelerant's website at https://investor.accelerant.ai/. Following the

    2/9/26 8:00:00 AM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Announces Third Quarter 2025 Results

    Exchange Written Premium of $1.043 billion grew 17% year-over-year and 39% on a year-to-date basis Net loss of $1.367 billion driven by non-cash and equity-neutral profits interest distribution expenses Adjusted net income of $79.8 million, up 320% over the prior year Net loss per basic and diluted share of $6.99, adjusted earnings per diluted share of $0.38 Adjusted EBITDA of $105.0 million and $66.3 million when excluding in-period investment gains (Adjusted EBITDA was up 302% year-over-year and 164% when excluding the investment gains) Additional key measures are presented below Accelerant Holdings (NYSE:ARX), a leading technology company operating a data-driven risk e

    11/12/25 4:15:00 PM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Announces Date of Third Quarter 2025 Financial Results and Conference Call

    Accelerant Holdings ("Accelerant") (NYSE:ARX), a leading technology company operating a data-driven risk exchange platform for the specialty insurance market, today announced that it will release financial results for the quarter ended September 30, 2025 before the market opens on Thursday, November 13, 2025. Accelerant will host a webcast and conference call to discuss third quarter financial results at 8:00 A.M. Eastern Time. Webcast and Conference Call Details When: November 13, 2025 at 8:00 A.M. Eastern Time. Webcast: A live webcast of the call can be accessed from the Investor Relations section of Accelerant's website at https://investor.accelerant.ai/. Following the call, a re

    10/3/25 8:00:00 AM ET
    $ARX
    Specialty Insurers
    Finance

    $ARX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Founder, Head of Distrib. Lee-Smith Christopher bought $197,240 worth of Class A Common Shares (14,700 units at $13.42), increasing direct ownership by 0.08% to 17,655,379 units (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    12/17/25 9:04:04 PM ET
    $ARX
    Specialty Insurers
    Finance

    Director Meriwether Karen Sue bought $7,951 worth of Class A Common Shares (542 units at $14.67), increasing direct ownership by 6% to 9,752 units (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    12/9/25 4:09:45 PM ET
    $ARX
    Specialty Insurers
    Finance

    Director Gaynor Samuel bought $100,774 worth of Class A Common Shares (7,500 units at $13.44) (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    11/20/25 4:17:43 PM ET
    $ARX
    Specialty Insurers
    Finance

    $ARX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Accelerant Holdings upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Accelerant Holdings from Mkt Perform to Mkt Outperform and set a new price target of $20.00

    12/4/25 8:19:30 AM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Holdings upgraded by Goldman with a new price target

    Goldman upgraded Accelerant Holdings from Neutral to Buy and set a new price target of $19.50

    10/6/25 8:19:36 AM ET
    $ARX
    Specialty Insurers
    Finance

    Piper Sandler initiated coverage on Accelerant Holdings with a new price target

    Piper Sandler initiated coverage of Accelerant Holdings with a rating of Overweight and set a new price target of $35.00

    8/18/25 8:53:58 AM ET
    $ARX
    Specialty Insurers
    Finance

    $ARX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Green Jay Michael covered exercise/tax liability with 200,637 units of Class A Common Shares, decreasing direct ownership by 14% to 1,254,214 units (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    2/4/26 4:05:48 PM ET
    $ARX
    Specialty Insurers
    Finance

    Co-Founder, Head of Distrib. Lee-Smith Christopher bought $197,240 worth of Class A Common Shares (14,700 units at $13.42), increasing direct ownership by 0.08% to 17,655,379 units (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    12/17/25 9:04:04 PM ET
    $ARX
    Specialty Insurers
    Finance

    Director Meriwether Karen Sue bought $7,951 worth of Class A Common Shares (542 units at $14.67), increasing direct ownership by 6% to 9,752 units (SEC Form 4)

    4 - Accelerant Holdings (0001997350) (Issuer)

    12/9/25 4:09:45 PM ET
    $ARX
    Specialty Insurers
    Finance

    $ARX
    Financials

    Live finance-specific insights

    View All

    Accelerant Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call

    Accelerant Holdings (NYSE:ARX), a leading technology company operating a data-driven risk exchange platform for the specialty insurance market, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the market opens on Thursday, March 19, 2026. Accelerant will host a webcast and conference call to discuss fourth quarter and full year financial results at 8:00 A.M. Eastern Time. Webcast and Conference Call Details When: March 19, 2026 at 8:00 A.M. Eastern Time. Webcast: A live webcast of the call can be accessed from the Investor Relations section of Accelerant's website at https://investor.accelerant.ai/. Following the

    2/9/26 8:00:00 AM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Announces Third Quarter 2025 Results

    Exchange Written Premium of $1.043 billion grew 17% year-over-year and 39% on a year-to-date basis Net loss of $1.367 billion driven by non-cash and equity-neutral profits interest distribution expenses Adjusted net income of $79.8 million, up 320% over the prior year Net loss per basic and diluted share of $6.99, adjusted earnings per diluted share of $0.38 Adjusted EBITDA of $105.0 million and $66.3 million when excluding in-period investment gains (Adjusted EBITDA was up 302% year-over-year and 164% when excluding the investment gains) Additional key measures are presented below Accelerant Holdings (NYSE:ARX), a leading technology company operating a data-driven risk e

    11/12/25 4:15:00 PM ET
    $ARX
    Specialty Insurers
    Finance

    Accelerant Announces Date of Third Quarter 2025 Financial Results and Conference Call

    Accelerant Holdings ("Accelerant") (NYSE:ARX), a leading technology company operating a data-driven risk exchange platform for the specialty insurance market, today announced that it will release financial results for the quarter ended September 30, 2025 before the market opens on Thursday, November 13, 2025. Accelerant will host a webcast and conference call to discuss third quarter financial results at 8:00 A.M. Eastern Time. Webcast and Conference Call Details When: November 13, 2025 at 8:00 A.M. Eastern Time. Webcast: A live webcast of the call can be accessed from the Investor Relations section of Accelerant's website at https://investor.accelerant.ai/. Following the call, a re

    10/3/25 8:00:00 AM ET
    $ARX
    Specialty Insurers
    Finance